Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Suraj Samtani; Mauricio Burotto; Juan Carlos Roman; Daniela Cortes-Herrera; Annerleim Walton-Diaz

doi:10.3390/diagnostics11091551

Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Suraj Samtani, Mauricio Burotto, Juan Carlos Roman, Daniela Cortes-Herrera, Annerleim Walton-Diaz^*

^*Corresponding author for this work

Clínica Universidad de los Andes

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

Original language	English
Article number	1551
Journal	Diagnostics
Volume	11
Issue number	9
DOIs	https://doi.org/10.3390/diagnostics11091551
State	Published - 27 Aug 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

Active surveillance
Artificial intelligence
Diagnosis
MRI
Prostate cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/diagnostics11091551

Cite this

@article{5e829a4edd194665b2a38249f1eb5a02,

title = "Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer",

abstract = "Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).",

keywords = "Active surveillance, Artificial intelligence, Diagnosis, MRI, Prostate cancer",

author = "Suraj Samtani and Mauricio Burotto and Roman, {Juan Carlos} and Daniela Cortes-Herrera and Annerleim Walton-Diaz",

note = "Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = aug,

day = "27",

doi = "10.3390/diagnostics11091551",

language = "English",

volume = "11",

journal = "Diagnostics",

issn = "2075-4418",

publisher = "MDPI AG",

number = "9",

}

TY - JOUR

T1 - Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

AU - Samtani, Suraj

AU - Burotto, Mauricio

AU - Roman, Juan Carlos

AU - Cortes-Herrera, Daniela

AU - Walton-Diaz, Annerleim

PY - 2021/8/27

Y1 - 2021/8/27

N2 - Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

AB - Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

KW - Active surveillance

KW - Artificial intelligence

KW - Diagnosis

KW - MRI

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85114040042&partnerID=8YFLogxK

U2 - 10.3390/diagnostics11091551

DO - 10.3390/diagnostics11091551

M3 - Review article

C2 - 34573893

AN - SCOPUS:85114040042

SN - 2075-4418

VL - 11

JO - Diagnostics

JF - Diagnostics

IS - 9

M1 - 1551

ER -

Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this